Literature DB >> 11070036

Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.

H Xia1, B Anderson, Q Mao, B L Davidson.   

Abstract

Some inborn errors of metabolism due to deficiencies of soluble lysosomal enzymes cause global neurodegenerative disease. Representative examples include the infantile and late infantile forms of the ceroid lipofuscinoses (CLN1 or CLN2 deficiency, respectively) and mucopolysaccharidoses type VII (MPS VII), a deficiency of beta-glucuronidase. Treatment of the central nervous system component of these disorders will require widespread protein or enzyme replacement, either through dissemination of the protein or through dissemination of a gene encoding it. We hypothesize that transduction of brain microcapillary endothelium (BME) with recombinant viral vectors, with secretion of enzyme product basolaterally, could allow for widespread enzyme dissemination. To achieve this, viruses should be modified to target the BME. This requires (i) identification of a BME-resident target receptor, (ii) identification of motifs targeted to that molecule, (iii) the construction of modified viruses to allow for binding to the target receptor, and (iv) demonstrated transduction of receptor-expressing cells. In proof of principal experiments, we chose the human transferrin receptor (hTfR), a molecule found at high density on human BME. A nonamer phage display library was panned for motifs which could bind hTfR. Forty-three clones were sequenced, most of which contained an AKxxK/R, KxKxPK/R, or KxK motif. Ten peptides representative of the three motifs were cloned into the HI loop of adenovirus type 5 fiber. All motifs tested retained their ability to trimerize and bind transferrin receptor, and seven allowed for recombinant adenovirus production. Importantly, the fiber-modified viruses facilitated increased gene transfer (2- to 34-fold) to hTfR expressing cell lines and human brain microcapillary endothelia expressing high levels of endogenous receptor. Our data indicate that adenoviruses can be modified in the HI loop for expanded tropism to the hTfR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070036      PMCID: PMC113241          DOI: 10.1128/jvi.74.23.11359-11366.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base.

Authors:  D A Einfeld; D E Brough; P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector.

Authors:  P Reynolds; I Dmitriev; D Curiel
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

3.  Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.

Authors:  S K Yoon; L Mohr; C R O'Riordan; A Lachapelle; D Armentano; J R Wands
Journal:  Biochem Biophys Res Commun       Date:  2000-06-07       Impact factor: 3.575

4.  Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis.

Authors:  P L Leopold; G Kreitzer; N Miyazawa; S Rempel; K K Pfister; E Rodriguez-Boulan; R G Crystal
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

5.  A simple method for the rapid generation of recombinant adenovirus vectors.

Authors:  R D Anderson; R E Haskell; H Xia; B J Roessler; B L Davidson
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

6.  Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.

Authors:  A Bosch; E Perret; N Desmaris; D Trono; J M Heard
Journal:  Hum Gene Ther       Date:  2000-05-20       Impact factor: 5.695

7.  Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.

Authors:  A F Skorupa; K J Fisher; J M Wilson; M K Parente; J H Wolfe
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

8.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

Authors:  T J Wickham; E Tzeng; L L Shears; P W Roelvink; Y Li; G M Lee; D E Brough; A Lizonova; I Kovesdi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.

Authors:  M J Staba; T J Wickham; I Kovesdi; D E Hallahan
Journal:  Cancer Gene Ther       Date:  2000-01       Impact factor: 5.987

10.  Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.

Authors:  T J Sferra; G Qu; D McNeely; R Rennard; K R Clark; W D Lo; P R Johnson
Journal:  Hum Gene Ther       Date:  2000-03-01       Impact factor: 5.695

View more
  33 in total

1.  Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.

Authors:  Lane K Law; Beverly L Davidson
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  Targeting gene therapy vectors to the vascular endothelium.

Authors:  Lorraine M Work; Stuart A Nicklin; Andrew H Baker
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

3.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.

Authors:  Natalya Belousova; Valentina Krendelchtchikova; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 5.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

6.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

7.  Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.

Authors:  A Pereboev; L Pereboeva; D T Curiel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 8.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

9.  Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.

Authors:  Natalya Belousova; Galina Mikheeva; Juri Gelovani; Victor Krasnykh
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.